Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
暂无分享,去创建一个
Faten Farouk | Wagdy M. Eldehna | Ayman Abo Elmaaty | A. A. Al-karmalawy | Haytham O. Tawfik | A. Elkamhawy | Radwan Alnajjar | Mohammed A. S. Abourehab | Haytham O Tawfik | Mohamed A. Saleh | A. Al-karmalawy
[1] S. Antar,et al. Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. , 2022, Journal of medicinal chemistry.
[2] Wagdy M. Eldehna,et al. Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies , 2022, International journal of molecular sciences.
[3] U. Abdelmohsen,et al. Potential topoisomerases inhibitors from Asergillus terreus using virtual screening , 2022, South African Journal of Botany.
[4] Mona El-Neketi,et al. Cytotoxic effects of extracts obtained from plants of the Oleaceae family: bio-guided isolation and molecular docking of new secoiridoids from Jasminum humile , 2022, Pharmaceutical biology.
[5] Mohamed Elagawany,et al. Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease , 2022, Journal of enzyme inhibition and medicinal chemistry.
[6] M. Ali,et al. Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies , 2022, Scientific Reports.
[7] K. Cherubini,et al. Erythromycin: an alternative for the management of oral mucositis? , 2022, Medicina oral, patologia oral y cirugia bucal.
[8] S. Antar,et al. A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways. , 2022, Life sciences.
[9] Wanqing Chen,et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.
[10] Khaled M. Darwish,et al. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity , 2021, ACS omega.
[11] Mohamed S. Nafie,et al. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies , 2021, Journal of enzyme inhibition and medicinal chemistry.
[12] A. Kandeil,et al. In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus , 2021, Comput. Biol. Medicine.
[13] E. Gomaa,et al. Design, Synthesis, Biological Evaluation, and SAR Studies of Novel Cyclopentaquinoline Derivatives as DNA Intercalators, Topoisomerase II Inhibitors, and Apoptotic Inducers , 2022, New Journal of Chemistry.
[14] S. Antar,et al. Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview , 2021, Vaccines.
[15] Mahmoud M. Shehata,et al. Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2 , 2021, Molecules.
[16] Khaled M. Darwish,et al. β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization , 2021, RSC advances.
[17] Walaa El-Kashak,et al. Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies , 2021, Journal of Herbmed Pharmacology.
[18] Muhammad I. Ismail,et al. Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies , 2021, Molecules.
[19] Chao Ma,et al. Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies , 2021, Frontiers in Chemistry.
[20] Khaled M. Darwish,et al. Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors , 2021, RSC advances.
[21] A. A. Al-karmalawy,et al. Computational repurposing of benzimidazole anthelmintic drugs as potential colchicine binding site inhibitors. , 2021, Future medicinal chemistry.
[22] A. Kandeil,et al. Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights , 2021, RSC advances.
[23] M. Elhefnawi,et al. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies , 2021, Heliyon.
[24] Katie Kingwell. Antibiotics switch to anticancer target , 2021, Nature Reviews Drug Discovery.
[25] Khaled M. Darwish,et al. Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies , 2021, Journal of Traditional and Complementary Medicine.
[26] Khaled M. Darwish,et al. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins , 2021, Journal of biomolecular structure & dynamics.
[27] T. Luedde,et al. Cancer Patients Have an Increased Incidence of Dementia: A Retrospective Cohort Study of 185,736 Outpatients in Germany , 2021, Cancers.
[28] M. M. Khalifa,et al. Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study , 2021, RSC advances.
[29] A. Karabay,et al. Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. , 2021, Leukemia research.
[30] I. El-Sayed,et al. Concanavalin-A shows synergistic cytotoxicity with tamoxifen via inducing apoptosis in estrogen receptor-positive breast cancer: In vitro and molecular docking studies , 2021, Pharmaceutical Sciences.
[31] A. Kandeil,et al. Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease , 2020, Heliyon.
[32] Wenyu Li,et al. Antibiotics for cancer treatment: A double-edged sword , 2020, Journal of Cancer.
[33] T. Efferth,et al. Repurposing old drugs to fight multidrug resistant cancers. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[34] A. Zaniboni,et al. Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies , 2019, Cancers.
[35] Wenfang Xu,et al. Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors , 2019, Molecules.
[36] Hisham A. Abbas,et al. Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa , 2017, African health sciences.
[37] Farag F. Sherbiny,et al. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents , 2017, Molecular Diversity.
[38] M. Reed. The Rescue and Repurposing of Pharmaceuticals: Augmenting the Drug Development Paradigm. , 2016, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[39] K. Rose,et al. ff ects of UV radiation on aquatic ecosystems and interactions with other environmental factors , 2014 .
[40] Mohammed Al-Shalalfa,et al. Prediction of novel drug indications using network driven biological data prioritization and integration , 2014, Journal of Cheminformatics.
[41] F. Sugawara,et al. A Eukaryotic Molecular Target Candidate of Roxithromycin: Fungal Differentiation as a Sensitive Drug Target Analysis System , 2013, Bioscience, biotechnology, and biochemistry.
[42] M. Utley,et al. Projections of cancer prevalence in the United Kingdom, 2010–2040 , 2012, British Journal of Cancer.
[43] H. Mukae,et al. Activity of Clarithromycin in Mucosa-Associated Lymphoid Tissue-Type Lymphomas: Response , 2011 .
[44] A. Ferreri. Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic? , 2011, Chest.
[45] Duane R. Romer. Synthesis of 2,3‐dichloroquinoxalines via Vilsmeier reagent chlorination , 2009 .
[46] B. Barlaam,et al. Novel 3‐Alkoxy‐1H‐pyrazolo[3,4‐d]pyrimidines as EGFR and erbB2 Receptor Tyrosine Kinase Inhibitors. , 2008 .
[47] Peter Ballard,et al. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[48] A. Fraser,et al. The anti-cancer effects of quinolone antibiotics? , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[49] Dorota Szumny,et al. Antitumor effect of macrolides – erythromycin and roxithromycin in B 16 melanoma-transplanted mice , 2007 .
[50] T. Aikou,et al. Roxithromycin Inhibits Constitutive Activation of Nuclear Factor κB by Diminishing Oxidative Stress in a Rat Model of Hepatocellular Carcinoma , 2005, Clinical Cancer Research.
[51] N. Osheroff,et al. Etoposide, topoisomerase II and cancer. , 2005, Current medicinal chemistry. Anti-cancer agents.
[52] D. Martincic,et al. Topoisomerase II inhibitors. , 2005, Cancer chemotherapy and biological response modifiers.
[53] L. Gianni,et al. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.
[54] J. E. Forero,et al. Cytotoxic and antiviral activities of Colombian medicinal plant extracts of the Euphorbia genus. , 2002, Memorias do Instituto Oswaldo Cruz.
[55] G. Liljegren,et al. Topoisomerase II-α Expression in Different Cell Cycle Phases in Fresh Human Breast Carcinomas , 2002, Modern Pathology.
[56] T. Hasegawa,et al. Reversal of Anticancer Drug Resistance by Macrolide Antibiotics in Vitro and in Vivo , 2000, Clinical and experimental pharmacology & physiology.
[57] Federico Gago,et al. Structure–affinity relationships for the binding of actinomycin D to DNA , 1997, J. Comput. Aided Mol. Des..
[58] R. Rill,et al. Binding of actinomycin D to the T(G)nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites. , 1994, Biochemistry.